Skip to content

Investigation for advanced cancer patients' treatment preferences and their end of life care

Investigation for advanced cancer patients' treatment preferences and their end of life care - Investigation for advanced cancer patients' treatment preferences and their end of life care

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000026436
Enrollment
400
Registered
2017-04-01
Start date
2017-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced cancer

Interventions

None listed

Sponsors

Nagoya City University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with advanced cancer and their primary caregiver 1. cancer with distant metastases 2. failure of first-line chemotherapy 3. treated in the participating institutions during the study period 4. 20 years of age or older 5. able to understand the Japanese language 6. in longitudinal observational study,patients were required to meet the following criteria: diagnosis of Stage IIIB or IV disease and failure of first-line chemotherapy within 2 months

Exclusion criteria

Exclusion criteria: 1. physically too ill to complete the questionnaire 2. severe mental disorders 3. severe cognitive disorders 4. judged by the treating physician to be unsuitable to participate

Design outcomes

Primary

MeasureTime frame
Comprehensive Quality of Life Outcome inventory (CoQoLo) at 3 months

Secondary

MeasureTime frame
PHQ-9 at 3months End of life treatment received Receipt of care consistent with preferences End of life discussion Good death in patient Good death in care giver Good death in physician Metacognitive Awareness Scale Beliefs about the effectiveness of chemotherapy Physician compassion scale

Countries

Japan

Contacts

Public ContactTakaaki Hasegawa

Nagoya City University Hospital Division of Palliative Care and Psycho-oncology

takaaki_hase@bird.ocn.ne.jp052-851-5511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026